Metriopharm
  • en
  • de
MetrioPharm AG
  • Home
  • About us
    • Our Company
    • Management and Board
    • Scientific Advisory Board
    • Career
  • Technology
    • MetrioPharm Platform
    • Mechanism of Action
    • Scientific Publications
  • Pipeline
    • Indication
    • Patent Protection
  • Investors
    • IR-News
    • Financial Report and Statutes
    • Annual General Meeting
  • Press
    • Press Releases
    • Corporate Calendar
  • Contact
    • Contact
    • Privacy policy
    • Imprint
  • en
  • de
  1. Home
  2. About us
  3. Sitemap

Sitemap

Get a quick overview:
We provide you a sitemap, which shows the structure of our website in a simple form.

 
  • Home
  • About us
    • Our Company
    • Management and Board
    • Scientific Advisory Board
    • Career
  • Technology
    • MetrioPharm Platform
    • Mechanism of Action
    • Scientific Publications
  • Pipeline
    • Indication
    • Patent Protection
  • Investors
    • IR-News
    • Financial Report and Statutes
    • Annual General Meeting
  • Press
    • Press Releases
    • Corporate Calendar
  • Contact
    • Contact
    • Privacy policy
    • Imprint
 

News

Dr. Stephan Rietiker elected as new Chairman of the Board of MetrioPharm AG - 2025-Apr-23

MetrioPharm AG announced today that the new Board of Directors unanimously elected Dr. Stephan Rietiker as Chairman at its constituent meeting

» more

Investor Relations

Investor-Update QI 2025 - 2025-Apr-03

Extraordinary General Meeting of MetrioPharm AG, Save the Date: Annual General Meeting of MetrioPharm AG, Company Calendar 2025, MetrioPharm AG informs

» more

Blog

Read our latest blog post: - 2021-May-12

Phase II Clinical Trial in COVID-19

» more

Navigation

  • Home
  • About us
  • Technology
  • Pipeline
  • Investors
  • Press
  • Contact

Social

        

Newsletter

Subscribe to our press releases with the
MetrioPharm PR newsletter

Investors can subscribe to our quaterly corporate information with the
MetrioPharm IR newsletter

Switzerland (HQ)

MetrioPharm AG

Europaallee 41
8004 Zurich

Phone: +41 44 552 7190

Germany (R&D)

MetrioPharm Deutschland GmbH

Am Borsigturm 100
13507 Berlin

Phone: +49 30 3384 395 02

  • © 2025 MetrioPharm AG
  • Imprint
  • Privacy policy (We don’t collect cookies)
  • Sitemap